Viewing Study NCT06184152



Ignite Creation Date: 2024-05-06 @ 7:56 PM
Last Modification Date: 2024-10-26 @ 3:16 PM
Study NCT ID: NCT06184152
Status: RECRUITING
Last Update Posted: 2024-01-03
First Post: 2023-12-04

Brief Title: CEUS vs AMRI for HCC Detection in Patients With Indeterminate Liver Nodules
Sponsor: University of Texas Southwestern Medical Center
Organization: University of Texas Southwestern Medical Center

Study Overview

Official Title: Contrast Ultrasound vs Abbreviated MRI for Detection of HCC in Patients With Indeterminate Liver Nodules
Status: RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The study will be conducted at the following locations

1 UT Southwestern Medical Center
2 Parkland Health and Hospital System
3 University of Michigan

Investigators will prospectively compare the performance of dynamic contrast enhanced abbreviated MRI AMRI and contrast-enhanced ultrasound for early-stage HCC detection in patients with indeterminate liver nodules
Detailed Description: Investigators will prospectively perform both abbreviated MRI and contrast-enhanced ultrasound in enrolled patients every 3-6 months Contrast-enhanced ultrasound and abbreviated MRI will preferably be done the same day although will be permitted to be completed within 30 days of each other Abbreviated MRI and contrast-enhanced ultrasound will be performed every 3-6 months until HCC development regression to LR-1 or LR-2 ie definitely or likely benign respectively or end of follow-up at 24 months post-enrollment

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None